← brief for 2026-09-05 · Slowing decline

CKD risk with tegoprazan versus proton pump inhibitors

Paper C Peer reviewed Observational

Key takeaways

This paper compares the risk of chronic kidney disease in people taking tegoprazan, a newer stomach acid drug, against people taking older acid drugs called proton pump inhibitors. Long term use of the older drugs has been tied to kidney problems before, so the question is whether the newer one is any safer. This compares people who were already taking these drugs, so it shows a link, not proof of cause. The posted record has no abstract, so the numbers behind the comparison are not available here.

Who did this work

Su Young Kim (Yonsei University) · Hyun-Soo Kim (Yonsei University) · Tae Sic Lee (Yonsei University) · Sangwon Hwang (Yonsei University) · Jun Young Lee (Gangneung–Wonju National University)

Source

Paper · OpenAlex, CKD works · 2026-09-04
https://doi.org/10.1093/ndt/gfag206